Prostatic zonal parameters and lower urinary tract symptoms as quantified via magnetic resonance imaging
DOI:
https://doi.org/10.5489/cuaj.8139Keywords:
benign prostatic hyperplasia, prostatic zones, intraprostatic protrusion, lower urinary tract symptoms, quality of lifeAbstract
INTRODUCTION: Benign prostatic hyperplasia (BPH) is a common diagnosis among aging males; however, the relationship between prostate volume and lower urinary tract symptom (LUTS) severity is imperfect. The goal of this study was to comprehensively investigate the relationship between various prostate zone-based parameters measured using magnetic resonance imaging (MRI) and LUTS.
METHODS: Data were retrospectively collected for 144 patients who underwent MRI between 2015 and 2017 at a single institution. Prostate volumes were measured on sagittal and axial T2 weighted using the prostate ellipsoid formula.
RESULTS: Only transition zone thickness (TZT) correlated with International Prostate Symptom Score (IPSS) (Pearson’s=0.33, p=0.007). The intraprostatic protrusion (IPP) component (rho=0.261, p=0.036), transitional zone volume (TZV) (rho=0.264, p=0.034), and TZT (Pearson’s correlation=0.422, p<0.001) all correlated with worsening quality of life (QoL) scores. In total, 97.9% of men had the presence of an IPP (>0 mm) and larger IPPs were found in older men with higher postvoid residual volumes. Larger peripheral zone volume (PZV) (odds ratio [OR] 3.62, 95% confidence interval [CI] 1.07–12.30, p<0.05), TZV (OR 6.00, 95% CI 1.69–21.35, p<0.05), and TZT (OR 4.00, 95% CI 1.17–13.69, p<0.05) were predictive of developing severe LUTS; however, IPP (p=0.122) was not.
CONCLUSIONS: TZV, TZT, and IPP all demonstrated a role in the evaluation of LUTS, with predictive capabilities. IPP is very common but not always clinically significant. Clarifying more precise zonal parameters and their relationship with LUTS may ultimately help clinicians guide the need for surgical intervention more precisely.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:
- Post the Article on any Web site
- Translate or authorize a translation of the Article
- Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
- Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.
The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.
You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.
The CUA also requires you to warrant the following:
- That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
- That all individuals who have made a substantive contribution to the article are acknowledged;
- That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
- That the Article does not libel or violate the privacy rights of any third party.